Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2D3P5 is a pseudogene, meaning it is a non-functional segment of DNA similar in sequence to the active UBE2D3 gene, which encodes ubiquitin-conjugating enzyme E2 D3. Pseudogenes like UBE2D3P5 are typically produced by gene duplication or retrotransposition and generally do not encode functional proteins or participate in cellular processes. All known molecular and disease roles relate to the protein-coding UBE2D3 gene, not this pseudogene. Querying UBE2D3P5 as a therapeutic target is likely due to database confusion or name similarity and is not scientifically accurate[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UBE2D3 pseudogene 5 (UBE2D3P5).